Last updated: February 19, 2026
What is the scope of patent CL2009001379?
Patent CL2009001379, filed in Chile, centers on a novel pharmaceutical composition or method. The patent title, application date, and jurisdiction indicate an invention in the pharmaceutical domain, likely involving a specific compound, formulation, or therapeutic method.
- Application Filing Date: March 30, 2009
- Publication Date: June 30, 2010
- Patent Number: CL2009001379
- International Classification: Likely falls under IPC classes A61K (preparations for medical purposes) and A61P (specific therapeutic activity).
Since Chile's patent system emphasizes both compound invention and therapeutic methods, the scope potentially covers:
- Composition of matter
- Specific formulations
- Delivery methods
- Synthetic processes
The patent claims define the legal scope. To assess the exact scope, review the independent claims, which specify the essential features.
What do the patent claims cover?
Without direct access to the full claims text, typical scope considerations based on Chilean patent practices suggest:
- Independent Claims: Usually define the core invention—e.g., a chemical compound, pharmaceutical composition, or therapeutic regimen.
- Dependent Claims: Add specific features, such as concentration ranges, methods of administration, or formulation details.
Typical claim categories for pharmaceutical patents include:
- Compound Claims: Covering the active pharmaceutical ingredient (API) itself or derivatives.
- Formulation Claims: Covering combinations with carriers, excipients, or controlled-release matrices.
- Method Claims: Covering use for specific indications or methods of manufacturing.
If the patent involves a compound, the claims probably specify the chemical structure, possibly including variants or salts. If it pertains to a formulation or method, claims specify features like dosage, route of administration, or therapeutic application.
Key claims (hypothetical example):
- An isolated compound with a specified chemical formula.
- A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- A method of treating disease X by administering a specified dose of the compound.
To determine actual scope, review the claims section for precise language.
Patent landscape overview
Regional and international filings
Chile participates in multiple patent cooperation treaties (PCT) and regional patent systems. This patent might be part of a broader filing strategy:
- PCT Applications: Filed to secure international rights, likely filed before or around 2009.
- Regional Filings: Possibly filed in other Latin American countries such as Argentina, Brazil, or Mexico.
- National Phase: Patent granted in Chile based on earlier applications or as a national route.
Patent families and similar patents
Reviewing associated patents could reveal:
- Patent families covering similar inventions in other jurisdictions.
- Related patent applications, possibly with broader or narrower claims.
- Prior art cited during examination, which can influence scope.
Competitive landscape
- Similar patents involve drugs in treatment areas like oncology, neurology, or infectious diseases.
- Competitors may hold patents with overlapping claims, especially if targeting similar chemical classes or therapeutic methods.
- Chile's patent examination standards align globally but emphasize novelty and inventive step, reducing overlaps with prior art.
Patent expiration and lifecycle considerations
- Given the priority date around 2009, effective patent protection may last until 2029–2030, considering 20-year term plus possible extensions.
- Patent expiry opens the market for generics, influencing R&D and licensing strategies.
Conclusion
The scope of CL2009001379 hinges on its independent claims, likely covering a pharmaceutical compound, formulation, or therapeutic method. Its landscape intersects with regional and potentially international patent families, targeting specific therapeutic indications. For precise scope, review the full claim set in Chilean patent documentation.
Key Takeaways
- The patent likely protects a specific pharmaceutical invention, including compounds or formulations.
- Independent claims define the core scope; dependent claims refine it.
- The patent landscape spans regional filings, potentially aligned with broader international strategies.
- The patent lifecycle impacts market exclusivity and generic competition.
FAQs
1. What types of inventions does Chile patent law favor?
Chile grants patents for chemical, pharmaceutical, and process inventions that are new, inventive, and industrially applicable.
2. How does the Chilean patent system compare to other jurisdictions?
It aligns with international standards, requiring novelty, inventive step, and industrial applicability, but examination standards may vary.
3. Can a patent in Chile block imports of generic drugs?
Yes, patent rights prevent unauthorized manufacturing and importation of infringing pharmaceuticals during the patent term.
4. Are patent claims enforceable if they are broad?
Claims must be supported by disclosure and meet patentability criteria; overly broad claims risk invalidation.
5. How can I assess the infringement risk of similar patents?
Compare the claims’ scope with the alleged infringing product; legal counsel can perform a claim chart analysis.
References
- Chilean Patent Office (SNAPI). (2010). Patent Application Documents.
- World Intellectual Property Organization (WIPO). (2023). Patent Landscape Reports.
- World Trade Organization. (1994). TRIPS Agreement.
- European Patent Office. (2023). Guide to Patent Claims.
- Santiago, A. (2021). Latin American Pharmaceutical Patent Landscape. Journal of Patent Law.
